FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:362-363 July 29, 1993 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kernan, N. A. PubMed Citation

To the Editor: Kernan et al. (March 4 issue)¹ report that patients who received marrow mismatched for one HLA antigen, as opposed to none, had delayed engraftment and an increased risk of a relapse of leukemia. However, there was no difference in the incidence of acute or chronic graft-versus-host disease, the incidence of secondary graft failure, or the Karnofsky score. These encouraging results suggest that more transplantations of marrow mismatched for one HLA antigen will be performed in the future. The paper describes HLA mismatches as minor if the mismatched antigen was cross-reactive and as major if the antigen was . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Rizzieri, D. A., Koh, L. P., Long, G. D., Gasparetto, C., Sullivan, K. M., Horwitz, M., Chute, J., Smith, C., Gong, J. Z., Lagoo, A., Niedzwiecki, D., Dowell, J. M., Waters-Pick, B., Liu, C., Marshall, D., Vredenburgh, J. J., Gockerman, J., Decastro, C., Moore, J., Chao, N. J. (2007). Partially Matched, Nonmyeloablative Allogeneic Transplantation: Clinical Outcomes and Immune Reconstitution. JCO 25: 690-697 [Abstract] [Full Text]